NeuOrphan
Biotechnology Research
This Gap Through the Development of Dioprotectome
6 employees
- Employees
- 6
NeuOrphan Overview
- Headquarters
- This Gap Through the Development of Dioprotectome
- Website
- neuorphan.com
- Industry
- Biotechnology Research
- Employees
- 6
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About NeuOrphan
NeuOrphan is developing a drug, currently in the preclinical stage of development, that aims to protect the central nervous system from inflammatory damage and promote repair through remyelination - addressing the unmet medical need in patients living with multiple sclerosis progression.
Compare Similar Companies to NeuOrphan
Wholesale Investor
Venture Capital And Private Equity Principals
Lifeline Loddon Mallee
Non-Profit Organizations
Trish Multiple Sclerosis Research Foundation
Research
DCRM Sciences
Biotechnology Research
Doye & Chalmel Frères
Investment Management
Yates Appellate Law
Legal Services
EPIC-X
Medical Equipment Manufacturing
Early-Career Complementologists (ECCO)
Non-Profit Organizations
Karmyo Media
Advertising Services
Titan Prehospital Innovation
Hospitals And Health Care